Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Rheumatol

Retrieve available abstracts of 348 articles:
HTML format



Single Articles


    April 2026
  1. OGUN H, Terlemez R, Palamar D, Akgun K, et al
    Evaluation of crystal-related arthritis in patients with knee effusion: insights from ultrasonography, microscopy and radiography.
    Clin Rheumatol. 2026;45:2319-2327.
    PubMed     Abstract available


  2. DONG K, Li M, Ye H, Xu Z, et al
    Elevated serum MMP3 levels as a potential biomarker of disease activity in primary Sjogren's syndrome: a prospective observational study.
    Clin Rheumatol. 2026;45:2287-2295.
    PubMed     Abstract available


  3. ZHANG Y, Duo R, Li Z, Liu Y, et al
    NEDD4L knockdown enhances synovial fibroblast migration, invasion, and inflammatory factor secretion via Wnt/beta-Catenin signaling activation.
    Clin Rheumatol. 2026;45:2385-2399.
    PubMed     Abstract available


    March 2026
  4. PAPAMICHAIL GV, Georgiadis NA, Xydis VG, Rapti I, et al
    Subclinical atherosclerosis in patients with undifferentiated connective tissue disease: comparison with rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 23. doi: 10.1007/s10067-026-08046.
    PubMed     Abstract available


  5. PARIKH A, Lewis G, GholamHosseini H, Ng KPL, et al
    Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis-a feasibility study.
    Clin Rheumatol. 2026 Mar 23. doi: 10.1007/s10067-026-08041.
    PubMed     Abstract available


  6. CRUZ-LOPEZ A, Rayo-Perez AM, Tovaruela-Carrion N, Tavara-Vidalon P, et al
    Effectiveness of physical exercise on foot pain and function in adults with rheumatoid arthritis: systematic review and meta-analysis.
    Clin Rheumatol. 2026 Mar 21. doi: 10.1007/s10067-026-08044.
    PubMed     Abstract available


  7. GUO R, Yang J, Zhang H, Zhang Y, et al
    Pharmacodynamic evaluation and mechanism study of cord blood nucleated cell extract in the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 21. doi: 10.1007/s10067-026-07979.
    PubMed     Abstract available


  8. SONG Z, Zhu D, Sun F, Geng J, et al
    CD161(+) Treg as a potential biomarker for evaluating disease activity and treatment efficacy in rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 20. doi: 10.1007/s10067-026-08056.
    PubMed     Abstract available


  9. YANG M, Xu F, Zhang B, Pi H, et al
    Age-stratified treatment response in rheumatoid arthritis: a systematic review, meta-analysis, and integrated genetic and single-cell evidence implicating IL6R/TYK2 signaling.
    Clin Rheumatol. 2026 Mar 18. doi: 10.1007/s10067-026-08029.
    PubMed     Abstract available


  10. ZERIHUN TE, Bekalu AF, Kasaw AT, Mussie DA, et al
    Determinant of health-related quality of life among patients with rheumatoid arthritis in North West Ethiopia, 2025: a multicenter cross-sectional study.
    Clin Rheumatol. 2026 Mar 11. doi: 10.1007/s10067-026-07956.
    PubMed     Abstract available


  11. VEGA-MORALES D, Machado P, Bergstra SA, la Fuente WO, et al
    Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning study.
    Clin Rheumatol. 2026 Mar 9. doi: 10.1007/s10067-026-08013.
    PubMed     Abstract available


  12. TAKAHASHI S, Takahashi M, Shinohara M, Saegusa J, et al
    Serum beta-hydroxybutyrate as a diagnostic biomarker distinguishing acute calcium pyrophosphate crystal arthritis from rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 7. doi: 10.1007/s10067-026-08016.
    PubMed     Abstract available


  13. SINGH P, Parab SB, Khan A, Doshi G, et al
    Protective effects of Syringic acid on joint inflammation and damage in a rat model of rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 6. doi: 10.1007/s10067-026-08020.
    PubMed     Abstract available


  14. GE W, Liang C, Wang Z, Fan C, et al
    Chest muscle area, spleen density, CD4 + T%, and C4 to predict the development of interstitial lung disease in patients with Sjogren's syndrome: a clinical prediction model.
    Clin Rheumatol. 2026;45:1741-1751.
    PubMed     Abstract available


  15. MOCRITCAIA A, Rivero A, Frade-Sosa B, Chacur C, et al
    T-cell large granular lymphocytic leukemia associated with palindromic rheumatism: A case report.
    Clin Rheumatol. 2026;45:2067-2069.
    PubMed     Abstract available


  16. LIU K, Zheng Z, Chen S, Liu Y, et al
    Immune thrombocytopenia in patients with connective tissue disease.
    Clin Rheumatol. 2026;45:1637-1650.
    PubMed     Abstract available


  17. WANG X, He S, Liang X, Bai W, et al
    Risk factors for disease progression in primary Sjogren's syndrome patients with low disease activity: a multicenter registry-based cohort study.
    Clin Rheumatol. 2026;45:1753-1763.
    PubMed     Abstract available


  18. PAN S, Xie X, Li T, Wu S, et al
    IL-33/ST2 induces Tfh cells activation and GCs formation in collagen-induced arthritis.
    Clin Rheumatol. 2026;45:2035-2046.
    PubMed     Abstract available


    February 2026
  19. LI Y, Xu K, Liu G, Li W, et al
    Comparison of agreement between three classification criteria for early rheumatoid arthritis (ERA) in Shanxi Province of China.
    Clin Rheumatol. 2026 Feb 28. doi: 10.1007/s10067-026-07990.
    PubMed     Abstract available


  20. KOYAMA K, Ohba T, Koizumi R, Watabe K, et al
    Maintaining clinical remission and preventing fractures are essential for preserving functional status over a 10-year period in patients with rheumatoid arthritis who have achieved Health Assessment Questionnaire-Disability Index remission: a retrospe
    Clin Rheumatol. 2026 Feb 21. doi: 10.1007/s10067-026-07997.
    PubMed     Abstract available


  21. ZHENG X, Ke X, Gao J, Luo X, et al
    Association between sex-hormone binding globulin and cardiovascular events in patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Feb 14. doi: 10.1007/s10067-026-07954.
    PubMed     Abstract available


  22. ZHANG S, Wang H, Jin Z, Cai X, et al
    Geriatric nutritional risk index and mortality risk in elderly patients with rheumatoid arthritis: evidence from NHANES (1999-2018).
    Clin Rheumatol. 2026 Feb 13. doi: 10.1007/s10067-026-07987.
    PubMed     Abstract available


  23. HIDAYAT R, Fauzia F, Audrey J, Larasati AP, et al
    Gastrointestinal adverse events among methotrexate users in rheumatoid arthritis patients: a systematic review and meta-analysis.
    Clin Rheumatol. 2026 Feb 7. doi: 10.1007/s10067-026-07975.
    PubMed     Abstract available


  24. ZHANG F, Wang LY, Wang P, Zhang J, et al
    Global temporal trends and projections of rheumatoid arthritis incidence among women of childbearing age: age-period-cohort analysis 2021.
    Clin Rheumatol. 2026 Feb 4. doi: 10.1007/s10067-025-07912.
    PubMed     Abstract available


  25. POLAK D, Kolasinska M, Wilk M, Dyczek L, et al
    Sleep disorders in RA, axSpA and PsA are common despite good disease activity control-direct comparison of sleep quality and its risk factors using MDHAQ and PSQI.
    Clin Rheumatol. 2026;45:957-965.
    PubMed     Abstract available


  26. WU G, Shi J, Gao C, Chen Q, et al
    Deciphering the molecular landscape of Sjogren's disease, mucosa-associated lymphoid tissue lymphoma, and thyroid cancer: unraveling the complexities of disease mechanisms and diagnostic biomarkers.
    Clin Rheumatol. 2026;45:1099-1115.
    PubMed     Abstract available


  27. CAMPINHO FERREIRA C, Bandeira M, Pereira da Costa R, Matias S, et al
    Safety and effectiveness of rituximab therapy in Sjogren's disease: a PORTRESS - the Portuguese registry of Sjogren's disease-based study.
    Clin Rheumatol. 2026;45:1091-1098.
    PubMed     Abstract available


  28. LI H, Zhang Q, Shen Z, Zeng Y, et al
    Unveiling dry eye with autoimmune features (DEAF): insights from a prospective longitudinal study.
    Clin Rheumatol. 2026;45:1079-1089.
    PubMed     Abstract available


  29. LI N, Huang H, Jia Y, Zhao L, et al
    Relapse risk after glucocorticoid withdrawal in stable Sjogren's disease-associated interstitial lung disease: a retrospective cohort study in China.
    Clin Rheumatol. 2026;45:1069-1078.
    PubMed     Abstract available


  30. KOSEHASANOGULLARI M, Sen SB, Yildirim A, Bilecik NA, et al
    Effects of cognitive-motor dual-task walking on gait and pain in primary Sjogren's syndrome: a comparative cross-sectional study.
    Clin Rheumatol. 2026;45:1059-1067.
    PubMed     Abstract available


  31. CUI Q, Zhou B, Feng Y, Huang Q, et al
    1400 plasma metabolites and Sjogren's syndrome: a Mendelian randomization analysis.
    Clin Rheumatol. 2026;45:1045-1058.
    PubMed     Abstract available


  32. SUN X, Zhou Z, Zhen T, Zhou Y, et al
    Decreased salivary ZG16B expression is associated with exocrine dysfunction in Sjogren disease.
    Clin Rheumatol. 2026;45:1033-1043.
    PubMed     Abstract available


  33. SU QY, Wang MY, Yang L, Xue CQ, et al
    Association of Th17/Treg immune imbalance and cardiovascular complications in RA patients: retrospective cohort study in refractory subgroups.
    Clin Rheumatol. 2026;45:707-716.
    PubMed     Abstract available


  34. ZHANG X, Wang R, Xu M, Li Q, et al
    Analyzing the expression of hsa-miR-661 in peripheral blood mononuclear cells of patients with primary Sjogren's syndrome and its clinical significance.
    Clin Rheumatol. 2026;45:1023-1031.
    PubMed     Abstract available


    January 2026
  35. MORRIS NT, Woodworth T, Pham A, Elashoff DA, et al
    Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic.
    Clin Rheumatol. 2026 Jan 31. doi: 10.1007/s10067-025-07754.
    PubMed     Abstract available


  36. HAJIALILOU N, Khabbazi A, Hajialilo M, Malek Mahdavi A, et al
    Comparing clinical outcomes of rheumatoid arthritis by onset type: palindromic rheumatism, undifferentiated arthritis, and typical rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 27. doi: 10.1007/s10067-026-07931.
    PubMed     Abstract available


  37. TADA M, Onishi K, Koike T, Anno S, et al
    Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice.
    Clin Rheumatol. 2026 Jan 21. doi: 10.1007/s10067-026-07944.
    PubMed     Abstract available


  38. PATEL SK, Meher J, Pandit VR, Samanta J, et al
    Foot and ankle arthritis in rheumatoid arthritis: prevalence and clinical correlation with disease activity.
    Clin Rheumatol. 2026 Jan 17. doi: 10.1007/s10067-026-07948.
    PubMed     Abstract available


  39. YEE J, Oakes EG, Santacroce L, Choi MY, et al
    Depression, anxiety, and post-traumatic stress disorder in association with cardiovascular disease among patients with systemic lupus erythematosus and rheumatoid arthritis in the All of Us Research Program.
    Clin Rheumatol. 2026 Jan 16. doi: 10.1007/s10067-026-07942.
    PubMed     Abstract available


  40. FU P, Zhou H, Li Y, Wang Y, et al
    Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007-2018.
    Clin Rheumatol. 2026 Jan 13. doi: 10.1007/s10067-026-07929.
    PubMed     Abstract available


  41. PAN X, Cui G, Wang L, Xiao Y, et al
    The role of musculoskeletal ultrasound in differentiating gouty arthritis from rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 9. doi: 10.1007/s10067-025-07921.
    PubMed     Abstract available


  42. ZHANG P, Wang S, Wu T, Su Z, et al
    Association between systemic inflammatory response index and cardiovascular disease risk in rheumatoid arthritis patients: a machine learning based on US and Chinese cohorts.
    Clin Rheumatol. 2026 Jan 8. doi: 10.1007/s10067-025-07915.
    PubMed     Abstract available


  43. ATTAR RZ, Chu R, Humphrey-Murto S, Mansour S, et al
    When it's not RA: unmasking Whipple's disease in seronegative, difficult-to-treat rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 2. doi: 10.1007/s10067-025-07886.
    PubMed     Abstract available


  44. BOURGUIBA R, Bellakhal S, Boudokhane M, Helali W, et al
    Usefulness of salivary gland ultrasonography in Sjogren's syndrome: The Tunisian Experience.
    Clin Rheumatol. 2026;45:251-255.
    PubMed     Abstract available


  45. LIU Z, Yang Y, Liu S, Zhang G, et al
    Initial assessment of blood-brain barrier permeability alterations and associated clinical characteristics in patients with primary Sjogren's syndrome: Insights from DCE-MRI.
    Clin Rheumatol. 2026;45:329-341.
    PubMed     Abstract available


  46. AJDER M, Cansu DU, Colak E, Teke HU, et al
    Etiologic spectrum and early mortality predictors in extreme hyperferritinemia: insights from rheumatology and hematology clinics.
    Clin Rheumatol. 2026;45:531-540.
    PubMed     Abstract available


  47. LEE KA, Kim YH, Kim HS
    Diagnostic concordance and added value of doppler ultrasound and extended histopathologic features in primary Sjogren disease.
    Clin Rheumatol. 2026;45:319-327.
    PubMed     Abstract available


  48. HAN F, Gao R, Fan H, Pu J, et al
    Telomere length in leukocyte as biomarker for diagnosis of primary Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2026;45:309-318.
    PubMed     Abstract available


  49. JUNFEI Z, Zhen Z, Fu Q, Meihua G, et al
    Identification of five novel hub genes associated with interstitial lung disease in primary Sjogren's syndrome via transcriptome sequencing.
    Clin Rheumatol. 2026;45:291-307.
    PubMed     Abstract available


  50. GROENER M, Baker H, Danve A
    VEXAS syndrome presenting with features of Sjogren's disease: a case-based review of VEXAS and autoimmune disease overlap.
    Clin Rheumatol. 2026;45:541-548.
    PubMed     Abstract available


  51. MO Y, Yang W, Li Y, Dai L, et al
    Clinical practice guideline for the treatment of Sjogren's disease through off-label drug use in China (English edition).
    Clin Rheumatol. 2026;45:257-269.
    PubMed     Abstract available


    December 2025
  52. MUTTIAH B, Wahab AA
    Cellular stress, cell death, and extracellular vesicles: redefining the therapeutic landscape of rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 24. doi: 10.1007/s10067-025-07887.
    PubMed     Abstract available


  53. ZHOU M, Zhu H, Zhang L, Huo Y, et al
    Disparities in clinical characteristics and health-related quality of life among young, young-onset elderly and elderly-onset rheumatoid arthritis patients: A large-scale national survey.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07895.
    PubMed     Abstract available


  54. SHABBIR AA, Afaq M, Mohsin O, Anvery SFA, et al
    Vagus nerve stimulation: a novel approach for refractory rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 18. doi: 10.1007/s10067-025-07875.
    PubMed    


  55. REN H, Ding N, Yu X, Teng J, et al
    Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction.
    Clin Rheumatol. 2025 Dec 16. doi: 10.1007/s10067-025-07854.
    PubMed     Abstract available


  56. YUAN J, Liu WZ, Wu DC, Jia FY, et al
    Non-linear association of admission platelet-to-lymphocyte ratio with 28- and 90-day mortality in critically ill patients with rheumatoid arthritis: a retrospective cohort study.
    Clin Rheumatol. 2025 Dec 9. doi: 10.1007/s10067-025-07853.
    PubMed     Abstract available


  57. SCHNEEBERGER EE, Perandones M, Rosemffet MG, Otaola M, et al
    Correction: Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 5. doi: 10.1007/s10067-025-07844.
    PubMed    


  58. SCHNEEBERGER EE, Felquer MLA, Citera G, Soriano E, et al
    Correction: Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Rheumatol. 2025 Dec 3. doi: 10.1007/s10067-025-07839.
    PubMed    


  59. SEO S, Cortinas MCB
    The impact of 24-h occupational stress on C-reactive protein and pain in a patient with rheumatoid arthritis: a 40-day prospective case study and literature review.
    Clin Rheumatol. 2025 Dec 2. doi: 10.1007/s10067-025-07859.
    PubMed     Abstract available


  60. JIN J, Jin Y, He J
    From endotypes to therapeutic targets: exploring the potential of precision treat-to-target approaches in primary Sjogren's disease.
    Clin Rheumatol. 2025;44:4797-4805.
    PubMed     Abstract available


  61. COUTINHO GC, Romao VC, Coutinho JC, Simao R, et al
    Corticosteroid irrigation of parotid glands for oral dryness in Sjogren's and non-Sjogren's sicca disease: a longitudinal study.
    Clin Rheumatol. 2025;44:4965-4974.
    PubMed     Abstract available


  62. LIANG H, Long M, Tie S, Dong S, et al
    Clinical characteristics and risk factors for the bidirectional association between immune thrombocytopenia and Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4955-4963.
    PubMed     Abstract available


    November 2025
  63. WANG Q, Yin J, Zhang M, Jia X, et al
    Letter to the editor: Inflammatory cytokines mediate the common genetic and immunological background between rheumatoid arthritis and osteoporosis.
    Clin Rheumatol. 2025 Nov 29. doi: 10.1007/s10067-025-07821.
    PubMed    


  64. QIAN B, Fang Z
    The association between oral microbiome diversity and rheumatoid arthritis: a nationwide cross-sectional study.
    Clin Rheumatol. 2025 Nov 22. doi: 10.1007/s10067-025-07835.
    PubMed     Abstract available


  65. ANGELOUDI E, Anyfanti P, Gavriilaki E, Pagkopoulou E, et al
    Asymmetric dimethylarginine and vascular injury in rheumatoid arthritis, from capillaries to large vessels: results from a cross-sectional study.
    Clin Rheumatol. 2025 Nov 22. doi: 10.1007/s10067-025-07816.
    PubMed     Abstract available


  66. LEI J, Wen Y, Li L, Ji H, et al
    High glucose-induced mitophagy accelerates premature aging of T cells in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Nov 20. doi: 10.1007/s10067-025-07815.
    PubMed     Abstract available


  67. VAN SOEST K, Ramiro S, Starmans-Kool MJF, Punt NC, et al
    Cost optimizing tocilizumab therapy in stable rheumatoid arthritis: a dose de-escalation nomogram to prevent overuse and unnecessary costs.
    Clin Rheumatol. 2025 Nov 13. doi: 10.1007/s10067-025-07796.
    PubMed     Abstract available


  68. ZHOU J, Dou X, Wu X, Li Y, et al
    Inflammatory cytokines mediate the common genetic and immunological background between rheumatoid arthritis and osteoporosis.
    Clin Rheumatol. 2025 Nov 7. doi: 10.1007/s10067-025-07693.
    PubMed     Abstract available


  69. ANDERSSON MLE, Wibring K, Bergman S, Bremander A, et al
    Empowerment as the key to health-enhancing physical activity in patients with rheumatoid arthritis and low physical function-a cross-sectional study.
    Clin Rheumatol. 2025 Nov 3. doi: 10.1007/s10067-025-07696.
    PubMed     Abstract available


  70. TENG HE, Tsai YH, Mo YC, Lu YJ, et al
    Elevated levels of nitrotyrosine-modified protein adducts and their association with the severity of primary sjogren's syndrome and secondary sjogren's syndrome with rheumatoid arthritis in Taiwanese Patients.
    Clin Rheumatol. 2025 Nov 1. doi: 10.1007/s10067-025-07730.
    PubMed     Abstract available


  71. YUAN M, Zhou Y, Long Z, Peng Y, et al
    Shared genetic architecture and potential comorbid mechanisms between rheumatoid arthritis and idiopathic pulmonary fibrosis.
    Clin Rheumatol. 2025 Nov 1. doi: 10.1007/s10067-025-07774.
    PubMed     Abstract available


  72. SAPUNDZHIEVA T, Sapundzhiev L, Karalilova R, Batalov A, et al
    Disease activity score for twenty-eight joints reflects different distribution of the inflammation as seen on ultrasound: A comparative ultrasound study in early rheumatoid and psoriatic arthritis.
    Clin Rheumatol. 2025;44:4727-4737.
    PubMed     Abstract available


  73. ASGHARVAND-HAJEB A, Shahmohammadi-Farid S, Saberivand M, Safary A, et al
    Molecular analysis of TNFAIP3, PTPN22, IRF5, and IL-10 gene polymorphisms in palindromic rheumatism.
    Clin Rheumatol. 2025;44:4759-4766.
    PubMed     Abstract available


  74. JIANG S, Dong Y, Wang Z, Liang M, et al
    Identification of shared diagnostic biomarkers and potential co-morbidity mechanisms between primary Sjogren's syndrome and chronic kidney disease.
    Clin Rheumatol. 2025;44:4577-4589.
    PubMed     Abstract available


  75. CORTES JS, Carvajal W, Correa A, Veloza K, et al
    Agreement between glandular ultrasonography and histopathology of minor salivary glands in adults with sicca syndrome.
    Clin Rheumatol. 2025;44:4567-4576.
    PubMed     Abstract available


    October 2025
  76. TADA M, Matsumoto Y, Koike T, Mamoto K, et al
    Biological/targeted synthetic disease-modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 31. doi: 10.1007/s10067-025-07767.
    PubMed     Abstract available


  77. EDITH SE, Laura AFM, Gustavo C, Enrique S, et al
    Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Rheumatol. 2025 Oct 29. doi: 10.1007/s10067-025-07700.
    PubMed     Abstract available


  78. MALDONADO-CANON K, Coral-Alvarado P, Mendez-Patarroyo P, Bautista-Molano W, et al
    ANAs and triple positivity effect on disease activity and sustained remission in rheumatoid arthritis: a retrospective real-world machine learning approach.
    Clin Rheumatol. 2025 Oct 24. doi: 10.1007/s10067-025-07683.
    PubMed     Abstract available


  79. XU J, Gong Y, Ding L, Luo Y, et al
    AIM2 as an Immunogenic Cell Death (ICD)-related hub gene in rheumatoid arthritis: identification and functional validation.
    Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07728.
    PubMed     Abstract available


  80. SHORTER E, Ossipova E, Alves ES, Idborg H, et al
    Health-enhancing physical activity induce beneficial skeletal muscle mitochondrial adaptations in individuals with rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07734.
    PubMed     Abstract available


  81. AKALTUN MS, Balbal E, Altindag O, Gur A, et al
    Ultrasonographic measurement of talar cartilage thickness in patients with rheumatoid arthritis and healthy controls.
    Clin Rheumatol. 2025 Oct 11. doi: 10.1007/s10067-025-07722.
    PubMed     Abstract available


  82. CUI M, Zhang C, Zhou Q, Ji M, et al
    Association of Apolipoprotein E polymorphism with lipoprotein metabolism and cardiovascular disease risk in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Oct 10. doi: 10.1007/s10067-025-07733.
    PubMed     Abstract available


  83. LIU X, Yuan PY, Zhang GH, Bu LH, et al
    The interactions between HLA alleles and immune indicators were associated with the risk of rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 8. doi: 10.1007/s10067-025-07729.
    PubMed     Abstract available


  84. ZHAO P, Song S, Cheng W, Peng C, et al
    Reduced TIGIT(+)CD56(+)NK cells associate with disease progression and impaired immune regulation in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4119-4131.
    PubMed     Abstract available


  85. LIU Y, Wang Q, Zhang Y, Duo R, et al
    Multi-omics characterization of gut microbiota and fecal and plasma metabolites in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4103-4118.
    PubMed     Abstract available


  86. LI RC, Liu XY, Fu L, Lan YY, et al
    Risk factors in systemic lupus erythematosus-associated Sjogren's syndrome: multicenter case-control studies and systematic review.
    Clin Rheumatol. 2025;44:4091-4101.
    PubMed     Abstract available


  87. WANG R, Wu J, Han Y, Zang S, et al
    Exploring gender-related clinical and immunological profiles in Sjogren's disease in a Chinese cohort.
    Clin Rheumatol. 2025;44:4081-4090.
    PubMed     Abstract available


  88. ANDREASSON S, Sodergren A
    Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis.
    Clin Rheumatol. 2025;44:3787-3799.
    PubMed     Abstract available


  89. ZHONG G, Zhang C, Xie W, Ding X, et al
    Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjogren's Syndrome-associated Interstitial Lung Disease.
    Clin Rheumatol. 2025;44:4071-4080.
    PubMed     Abstract available


  90. WANG Q, Zhang Y, Zhang H, Chen Z, et al
    Suboptimal methotrexate utilization in Chinese patients with inflammatory arthritis: data from a Chinese center.
    Clin Rheumatol. 2025;44:3829-3833.
    PubMed     Abstract available


    September 2025
  91. LAI SW, Kuo YH, Liao KF
    Association between rheumatoid arthritis and thyroid cancer risk: a real-world cohort study using TriNetX.
    Clin Rheumatol. 2025 Sep 29. doi: 10.1007/s10067-025-07668.
    PubMed     Abstract available


  92. WANG Q, Anthony DD
    Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study.
    Clin Rheumatol. 2025 Sep 27. doi: 10.1007/s10067-025-07709.
    PubMed     Abstract available


  93. RODRIGUES LSS, Feyo VB, Provinciali LS, Pereira JJ, et al
    Association between tooth loss and clinical complications in rheumatoid arthritis: a pilot study.
    Clin Rheumatol. 2025 Sep 23. doi: 10.1007/s10067-025-07647.
    PubMed     Abstract available


  94. SALIEVA RS, Zhumabaeva S, Isakov U, Sakibaev K, et al
    The role of sequential biologic therapy in rheumatoid arthritis: a systematic review and meta-analysis of efficacy, safety, and predictive factors.
    Clin Rheumatol. 2025 Sep 11. doi: 10.1007/s10067-025-07636.
    PubMed     Abstract available


  95. ZHU K, Zhang X, Chen G, Zhu Y, et al
    Treatment effectiveness of hydroxychloroquine in patients with primary Sjogren's syndrome: a real-world Study.
    Clin Rheumatol. 2025;44:3591-3603.
    PubMed     Abstract available


  96. HUI M, Deng X, Wang J, Qian J, et al
    The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:3581-3590.
    PubMed     Abstract available


    August 2025
  97. PRASAD CB, Dhir V, Gupta R, Thomas KN, et al
    Split vs single-dose oral methotrexate in rheumatoid arthritis: a randomized controlled trial (SMART study).
    Clin Rheumatol. 2025 Aug 29. doi: 10.1007/s10067-025-07646.
    PubMed     Abstract available


  98. AL-JEDAI A, Al-Mudaiheem H, Alghanim N, Alhomood I, et al
    Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins.
    Clin Rheumatol. 2025 Aug 21. doi: 10.1007/s10067-025-07644.
    PubMed     Abstract available


  99. YIN J, Zhang M, Jia X
    Letter to the editor: clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 19. doi: 10.1007/s10067-025-07660.
    PubMed    


  100. SUNNER S, Jones B, Jones CA, Al Hamarneh YN, et al
    Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study.
    Clin Rheumatol. 2025 Aug 12. doi: 10.1007/s10067-025-07615.
    PubMed     Abstract available


  101. LU YC, Chen YC
    Ultrasound of the wrist in low disease rheumatoid arthritis patients: Intercarpal joint is more sensitive than radio-carpal and distal radio-ulnar joint.
    Clin Rheumatol. 2025 Aug 6. doi: 10.1007/s10067-025-07625.
    PubMed     Abstract available


  102. CAI T, Tao Y, Pan Q, Yang L, et al
    Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07590.
    PubMed     Abstract available


  103. LI S, Zhang J, Li J, Liu W, et al
    Nonlinear association between rheumatoid factor and interstitial lung disease risk in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07627.
    PubMed     Abstract available


  104. ZHANG Y, Liang Y, Liu M, Liu L, et al
    Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28(+) CD45RA(+) CD8(br) treg cells.
    Clin Rheumatol. 2025 Aug 2. doi: 10.1007/s10067-025-07605.
    PubMed     Abstract available


  105. DOZET M, Fugosic Mesic V, Laskarin AM, Drvar V, et al
    Salivary and serum biomarkers profile of patients with rheumatoid arthritis and temporomandibular disorders.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07593.
    PubMed     Abstract available


  106. ANYFANTI P, Antza C, Ainatzoglou A, Angeloudi E, et al
    Sodium, potassium intake and urinary sodium-to-potassium ratio in rheumatoid arthritis: association with markers of cardiovascular dysfunction and disease-related parameters.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07608.
    PubMed     Abstract available


  107. KOYAMA K, Ohba T, Koizumi R, Haro H, et al
    Prevalence and Predictors of Residual Symptoms in Rheumatoid Arthritis Patients in SDAI Remission: A Cross-Sectional Study Using the Illustrated Okomarigoto Sheet.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07592.
    PubMed     Abstract available


    July 2025
  108. RAO P, Jin S, Zhang B, Li R, et al
    Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07565.
    PubMed     Abstract available


  109. KOMIYA Y, Sugihara T, Ishizaki T, Kimura N, et al
    The impact of aging and glucocorticoid use on physical function of older rheumatoid arthritis in remission: analysis of a National Database of Rheumatic Disease in Japan.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07599.
    PubMed     Abstract available


  110. ZHA X, Liu M, Ruan S, Jiang Y, et al
    Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease.
    Clin Rheumatol. 2025 Jul 26. doi: 10.1007/s10067-025-07587.
    PubMed     Abstract available


  111. MAS MARIN J, Molina-Olano M, Sola NR, Miserachs-Aranda N, et al
    Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568.
    PubMed     Abstract available


  112. TUZUN Z, Aydin K, Turk I, Varkal G, et al
    Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07589.
    PubMed     Abstract available


  113. LI Z, Liu Y, Zhang Y, Zhang Z, et al
    NETs promote fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cell response in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07543.
    PubMed     Abstract available


  114. HUANG J, Wang L, Hu X, Wang T, et al
    Genetic and molecular underpinnings of the link between rheumatoid arthritis and myasthenia gravis: Insights from GWAS and transcriptomic analyses.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07582.
    PubMed     Abstract available


  115. OZ B, Dogan Y, Karatas A, Koca SS, et al
    Radiological and serological predictors of cavitary transformation in rheumatoid arthritis-associated pulmonary nodules: a retrospective cohort study.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07579.
    PubMed     Abstract available


  116. ZOU L, Fan Q, Liu Y, He H, et al
    Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07545.
    PubMed     Abstract available


  117. REN Y, Xia W, Wu J, Yang Z, et al
    Artificial intelligence-based prediction of organ involvement in Sjogren's syndrome using labial gland biopsy whole-slide images.
    Clin Rheumatol. 2025;44:2919-2927.
    PubMed     Abstract available


  118. CHENG F, Wang YL, Ai XY, Liu Y, et al
    Clinical features of anti-RNP-positive primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2911-2917.
    PubMed     Abstract available


  119. TURKMEN S, Coskuner T, Sozeri B
    Multidimensional assessment of Juvenile Sjogren disease.
    Clin Rheumatol. 2025;44:2897-2909.
    PubMed     Abstract available


  120. GU X, Chen Y, Xuan J, Shi Y, et al
    Positive thyroid autoantibodies in primary Sjogren syndrome define a subset of patients with milder disease.
    Clin Rheumatol. 2025;44:2889-2895.
    PubMed     Abstract available


  121. JONUSIENE G, Kaceniene A, Gedvilaite V, Dadoniene J, et al
    Cancer risk in patients with Sjogren's syndrome in Lithuanian cohort study.
    Clin Rheumatol. 2025;44:2883-2887.
    PubMed     Abstract available


    June 2025
  122. EDITH SE, Miguel P, Gabriel RM, Maria O, et al
    Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510.
    PubMed     Abstract available


  123. AKBARI AR, Alam B
    Medication effects on uric acid levels in rheumatoid arthritis studies.
    Clin Rheumatol. 2025 Jun 20. doi: 10.1007/s10067-025-07538.
    PubMed    


  124. JIN J, Xiang X, Cai X, Hou Y, et al
    Machine learning and bioinformatics analysis to identify and validate diagnostic model associated with immune infiltration in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 11. doi: 10.1007/s10067-025-07514.
    PubMed     Abstract available


  125. KARACAOGLU MC, Kizildag B, Okyar B, Yildirim Cetin G, et al
    Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.
    Clin Rheumatol. 2025 Jun 9. doi: 10.1007/s10067-025-07511.
    PubMed     Abstract available


  126. OSKEN S, Osken A, Polat F, Sahin D, et al
    A retrospective study of electrocardiographic alterations in primary Sjogren's syndrome: role of anti-SSA positivity and disease duration.
    Clin Rheumatol. 2025;44:2377-2386.
    PubMed     Abstract available


  127. SU R, Wang H, Li B, Wu R, et al
    Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model.
    Clin Rheumatol. 2025;44:2487-2500.
    PubMed     Abstract available


  128. QI X, Zhao D, Wang N, Han Y, et al
    B lymphocyte subset-based stratification in primary Sjogren's syndrome: implications for lymphoma risk and personalized treatment.
    Clin Rheumatol. 2025;44:2403-2412.
    PubMed     Abstract available


  129. DOU H, Wu R, Wang H, Wang X, et al
    CCR5 + T cells as a potential biomarker for primary Sjogren's disease based on bioinformatics analysis.
    Clin Rheumatol. 2025;44:2387-2401.
    PubMed     Abstract available


  130. LUO Y, Mo Y, Li S, Yao J, et al
    Value of combined application of the OMERACT scoring system and shear wave elastography for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2367-2375.
    PubMed     Abstract available


  131. FAN R, Zhang Z, Huang Q, Liu L, et al
    Association of regional adiposity distribution with risk of autoimmune diseases.
    Clin Rheumatol. 2025;44:2541-2552.
    PubMed     Abstract available


  132. WANG C, Hu H, Xu Y, Wang S, et al
    Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2355-2365.
    PubMed     Abstract available


  133. WANG Z, Chen X, Zhang QB, Wang H, et al
    Exploring the genetic components and multi-omics sources of inflammatory bowel disease from the perspective of autoimmune disorders.
    Clin Rheumatol. 2025;44:2527-2539.
    PubMed     Abstract available


  134. DUO R, Wang Y, Ma Q, Wang X, et al
    MTX-induced gastrointestinal reactions in RA: Prevotella enrichment, gut dysbiosis, and PI3K/Akt/Ras/AMPK pathways.
    Clin Rheumatol. 2025;44:2163-2177.
    PubMed     Abstract available


    May 2025
  135. MUSTONEN AM, Savinainen J, Lehtonen M, Lehenkari P, et al
    Synovial fluid o-tyrosine is a potential biomarker for autoimmune-driven rheumatoid arthritis.
    Clin Rheumatol. 2025 May 31. doi: 10.1007/s10067-025-07491.
    PubMed     Abstract available


  136. RAO P, Jin S, Qi Y, Liu X, et al
    Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 May 22. doi: 10.1007/s10067-025-07493.
    PubMed     Abstract available


  137. YAN L, Xu J, Ye X, Lin M, et al
    Development and validation of ultrasound-based radiomics deep learning model to identify bone erosion in rheumatoid arthritis.
    Clin Rheumatol. 2025 May 19. doi: 10.1007/s10067-025-07481.
    PubMed     Abstract available


  138. ZHENG X, Ke X, Gao J, Zheng Z, et al
    The molecular basis of all-trans retinoic acid binding to the target genes involved in rheumatoid arthritis through network pharmacology and molecular docking.
    Clin Rheumatol. 2025 May 17. doi: 10.1007/s10067-025-07482.
    PubMed     Abstract available


  139. WU T, Wang Y, Xia Y, Ji J, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases.
    Clin Rheumatol. 2025 May 16. doi: 10.1007/s10067-025-07485.
    PubMed     Abstract available


  140. PHAM TH, Do TTH, Nguyen TN, Luu LC, et al
    Characteristics of sarcopenia in patients with rheumatoid arthritis at a central university hospital in Hanoi, Vietnam: a cross-sectional study.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07469.
    PubMed     Abstract available


  141. TEMIZ KARADAG D, Dogan S, Cakir O, Altintas Y, et al
    The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07443.
    PubMed     Abstract available


  142. GOMES-SILVA JM, Torres CP, Teixeira LR, Saraiva MDCP, et al
    Prospective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjogren's disease.
    Clin Rheumatol. 2025;44:1971-1982.
    PubMed     Abstract available


  143. LI X, Li Y, Luo Q, Yang W, et al
    Direct immunofluorescence of labial gland in diagnosis of Sjogren's disease.
    Clin Rheumatol. 2025;44:1961-1969.
    PubMed     Abstract available


  144. YANG Y, Zhang Y, Liu K, Liu M, et al
    IFI27, a potential candidate molecular marker for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1949-1960.
    PubMed     Abstract available


    April 2025
  145. XU QY, Liu YQ, Tong WQ, Yin-Ruo YR, et al
    Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching.
    Clin Rheumatol. 2025 Apr 29. doi: 10.1007/s10067-025-07431.
    PubMed     Abstract available


  146. MA Z, Wu S, Xiong LE, Zhong J, et al
    Interaction of nutritional and inflammatory levels on all-cause mortality among individuals with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07458.
    PubMed     Abstract available


  147. YANG D, Chen J, He G, Zhou Z, et al
    Comparisons of [(68) Ga]Ga-FAPI-04 PET/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07414.
    PubMed     Abstract available


  148. ZHAO P, Yuan K, Tang Z, Li Y, et al
    Investigation of hub-shared genes and regulatory mechanisms of rheumatoid arthritis and atherosclerosis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07423.
    PubMed     Abstract available


  149. MALEKAN M, Dozandeh-Jouybari A, Sadeghian N, Soltanshahi M, et al
    SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity.
    Clin Rheumatol. 2025 Apr 26. doi: 10.1007/s10067-025-07461.
    PubMed     Abstract available


  150. WU Q, Zhang X, Qin M, Shi D, et al
    Dual roles of LncRNA RNA143598: a biomarker for rheumatoid arthritis and its implications in cancer.
    Clin Rheumatol. 2025 Apr 25. doi: 10.1007/s10067-025-07448.
    PubMed     Abstract available


  151. CELIK NC, Kilinc EA
    Assessment of ChatGPT's adherence to EULAR diagnostic criteria and therapeutic protocols for rheumatoid arthritis at two distinct time points, 14 days apart, utilizing binary and multiple-choice inquiries.
    Clin Rheumatol. 2025 Apr 22. doi: 10.1007/s10067-025-07417.
    PubMed     Abstract available


  152. THYBERG I, Husberg M, Kastbom A
    Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions.
    Clin Rheumatol. 2025 Apr 9. doi: 10.1007/s10067-025-07399.
    PubMed     Abstract available


  153. LEBOUILLE-VELDMAN AB, Huizinga TWJ, Mekary RA, Vleggeert-Lankamp CLA, et al
    Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity.
    Clin Rheumatol. 2025 Apr 4. doi: 10.1007/s10067-025-07408.
    PubMed     Abstract available


  154. YANG J, Park Y, Lee JJ, Kim WU, et al
    Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity, and lymphoma risk factors in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1643-1652.
    PubMed     Abstract available


  155. HAKBILEN S, Tezcan D, Onmaz DE, Yilmaz S, et al
    The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1635-1642.
    PubMed     Abstract available


  156. HAN Y, Wang R, Sun F, Feng R, et al
    Anti-SSA/SSB antibody double-negative Sjogren's disease patients: a comprehensive clinical study and immune profile.
    Clin Rheumatol. 2025;44:1625-1633.
    PubMed     Abstract available


  157. XU Y, Yin Y, Li W, Zhou J, et al
    Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy.
    Clin Rheumatol. 2025;44:1705-1712.
    PubMed     Abstract available


    March 2025
  158. GENG L, Li T, Liu Y, Liu X, et al
    Lycium barbarum polysaccharide corrects CCR9(+) Th17/ Treg imbalance in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 27. doi: 10.1007/s10067-025-07415.
    PubMed     Abstract available


  159. LI F, Xian D, Yang K
    Mendelian randomization and mediation analysis reveal the role of immune cell subsets in the causal pathways between blood cell perturbation responses and rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 12. doi: 10.1007/s10067-025-07387.
    PubMed     Abstract available


  160. ANGELOZZI L, Gillibert A, Brevet P, Grosjean J, et al
    Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.
    Clin Rheumatol. 2025 Mar 10. doi: 10.1007/s10067-025-07390.
    PubMed     Abstract available


  161. ZHAO C, Xiao Q, Huang W, Chen Y, et al
    Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data.
    Clin Rheumatol. 2025 Mar 6. doi: 10.1007/s10067-025-07386.
    PubMed     Abstract available


  162. YU X, Xi J, Wu J, Song R, et al
    Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop?.
    Clin Rheumatol. 2025 Mar 5. doi: 10.1007/s10067-025-07380.
    PubMed     Abstract available


  163. SONG S, Yang Y, Ren T, Shen Y, et al
    Enhanced co-expression of TIGIT and PD-1 on gammadelta T cells correlates with clinical features and laboratory parameters in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1245-1257.
    PubMed     Abstract available


  164. PEI W, Xu L, Zhong H, Wang Z, et al
    Clinical features of inflammatory arthritis in daily practice-China's perspective.
    Clin Rheumatol. 2025;44:969-978.
    PubMed     Abstract available


  165. LIANG Y, Zhang Z, Li J, Yang Z, et al
    Association of increased serum I-309 with phenotypes, disease activity, and cytokine pattern in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1237-1243.
    PubMed     Abstract available


  166. HUGHES DM, Yiu ZZN, Zhao SS
    External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
    Clin Rheumatol. 2025;44:1151-1161.
    PubMed     Abstract available


  167. PANG F, Jiang Q, Tang X, Li K, et al
    Fecal metabolomic analysis of the role of gut microbiota and short-chain fatty acids in the therapeutic mechanism of Timosaponin AIII in Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1209-1223.
    PubMed     Abstract available


  168. LIANG P, Huang Y, Hu Z, Zhou L, et al
    Clinical and laboratory characteristics of Sjogren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.
    Clin Rheumatol. 2025;44:1225-1236.
    PubMed     Abstract available


  169. VIEGAS-COSTA LC, Friesen R, Lai H, McGaw T, et al
    Serology and histology in Sjogren's syndrome diagnosis: a retrospective accuracy study.
    Clin Rheumatol. 2025;44:1197-1207.
    PubMed     Abstract available


    February 2025
  170. LI Y, Zhong S, Huang S, Zhong W, et al
    Application of metabolomics in the classification of traditional Chinese medicine syndromes in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 26. doi: 10.1007/s10067-025-07373.
    PubMed     Abstract available


  171. TASAMMA AT, Eshetu BZ, Seyoum AT, Woldegiorgis SA, et al
    Differences in rates of remission between rheumatoid factor positive and negative rheumatoid arthritis patients: experience from a resource-limited setting.
    Clin Rheumatol. 2025 Feb 25. doi: 10.1007/s10067-025-07370.
    PubMed     Abstract available


  172. VISWANATHAN A, Brahma N, Vimal S
    The future of autoimmune disease care: merging genomic insights and imaging for enhanced prognosis in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 22. doi: 10.1007/s10067-024-07234.
    PubMed    


  173. SAIDI AN, Theel WB, Burggraaf B, van der Lelij AJ, et al
    Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 17. doi: 10.1007/s10067-025-07364.
    PubMed     Abstract available


  174. WU H, Yin F, Wang Y, Tang Z, et al
    Increased macrophage migration inhibitory factor is associated with inflammation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 14. doi: 10.1007/s10067-025-07361.
    PubMed     Abstract available


  175. MIKAEILI B, Alqahtani ZA, Hincapie AL, Guo JJ, et al
    Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.
    Clin Rheumatol. 2025 Feb 13. doi: 10.1007/s10067-025-07360.
    PubMed     Abstract available


  176. MUSAEVA LM, Shestakova KM, Baskhanova SN, Varzieva VG, et al
    Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions.
    Clin Rheumatol. 2025 Feb 10. doi: 10.1007/s10067-025-07355.
    PubMed     Abstract available


  177. NANKI T, Yamaguchi T, Umetsu K, Tanabe R, et al
    Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07328.
    PubMed     Abstract available


  178. WANG H, Chu J, Wang Y, Wu Y, et al
    Mediating effect of X-26109 on the causal relationship between CD14(+) CD16(-) monocyte activation complex and rheumatoid arthritis in Europe.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07300.
    PubMed     Abstract available


  179. HAMMAM N, El-Hadidi T, El-Hadidi K, Elsaman A, et al
    International overview on juvenile-, adult- and elderly-onset rheumatoid arthritis: The age at disease onset as a fundamental determinant of clinical presentation.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07356.
    PubMed     Abstract available


  180. QWABE N, Paruk F, Mody GM
    Low prevalence of methotrexate intolerance in rheumatoid arthritis: a South African study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07310.
    PubMed     Abstract available


  181. XIE X, Wei G, Tang Z, Chen H, et al
    Investigating the causal relationship between rheumatoid arthritis and cardiovascular disease: A Mendelian randomization study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07357.
    PubMed     Abstract available


  182. WU B, Dong Q, Zhang Q, Jin F, et al
    Protective effects of Catalpol to attenuate TNF- alpha and collagen-induced inflammation in vitro HFLS-RA cells and in vivo mice models for the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 5. doi: 10.1007/s10067-024-07261.
    PubMed     Abstract available


  183. LONG D, Zhan J, Tu C, Yu S, et al
    Analysis of expression and its clinical significance of the ADAMTS-2 in systemic lupus erythematosus.
    Clin Rheumatol. 2025;44:681-691.
    PubMed     Abstract available


  184. LIAO Q, Zhao Y, Li X, Li X, et al
    Cerebral venous thrombosis as a rare complication of Sjogren's syndrome: case series and literature review.
    Clin Rheumatol. 2025;44:739-746.
    PubMed     Abstract available


    January 2025
  185. MOHAN A, Mohan A, Ramachandran A, Pulinilkunnathil JG, et al
    Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predispositio
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07351.
    PubMed     Abstract available


  186. UZUN GS, Sarikaya Y, Arslan S, Ekici M, et al
    ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07344.
    PubMed     Abstract available


  187. PERNIOLA S, Bruno D, Di Mario C, Campobasso D, et al
    Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission.
    Clin Rheumatol. 2025 Jan 22. doi: 10.1007/s10067-025-07331.
    PubMed     Abstract available


  188. HUANG Y, Li T, An Y, Lu D, et al
    Molecular mechanism of osteoclast differentiation of PBMC in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07322.
    PubMed     Abstract available


  189. XU B, Yu C
    Letter to editor "Health?related quality of life (HRQoL) loss associated with self?perceived anxiety/depression in seropositive rheumatoid arthritis".
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-024-07260.
    PubMed    


  190. SENER S, Sener YZ
    Letter to the editor: Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findi
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-025-07330.
    PubMed    


  191. WU S, Xie Y, Jiang Y, Zhang X, et al
    GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the a7nAch receptor.
    Clin Rheumatol. 2025 Jan 15. doi: 10.1007/s10067-025-07320.
    PubMed     Abstract available


  192. HU X, Liu X, Xu Y, Zhang S, et al
    Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis.
    Clin Rheumatol. 2025 Jan 10. doi: 10.1007/s10067-025-07304.
    PubMed     Abstract available


  193. ALRIFAI N, Puttur A, Ghanem F, Dhital Y, et al
    Maternal and fetal outcomes in those with autoimmune connective tissue disease.
    Clin Rheumatol. 2025;44:391-401.
    PubMed     Abstract available


  194. KOPPEJAN H, Smith SI, Hameetman M, Toes REM, et al
    A small-scale preliminary study utilizing mass cytometry to distinguish two forms of arthritis.
    Clin Rheumatol. 2025;44:495-502.
    PubMed     Abstract available


  195. MANDOSI C, Matys V, Deroma M, Del Negro V, et al
    Ovarian reserve in patients with Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2025;44:319-325.
    PubMed     Abstract available


  196. FAYET F, Beauvais C, Pereira B, Beranger M, et al
    Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.
    Clin Rheumatol. 2025;44:487-494.
    PubMed     Abstract available


  197. PANG R, Ma X, Guo H, Qi X, et al
    Meta-analysis of mortality-associated factors in primary Sjogren's syndrome patients with interstitial lung disease.
    Clin Rheumatol. 2025;44:23-31.
    PubMed     Abstract available


    December 2024
  198. TANG M, Du L, Peng J
    Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.
    Clin Rheumatol. 2024 Dec 30. doi: 10.1007/s10067-024-07272.
    PubMed     Abstract available


  199. ZHOU W, Yang Y, Su L
    Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07282.
    PubMed     Abstract available


  200. HIJJAWI N, Tout FS, Azaizeh B, Aljaafreh B, et al
    The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07285.
    PubMed     Abstract available


  201. WAN J, Cao X, Yang Y
    Decreased in-hospital mortality in shock patients with rheumatoid arthritis compared to those without: a retrospective analysis of a critical care database.
    Clin Rheumatol. 2024 Dec 24. doi: 10.1007/s10067-024-07280.
    PubMed     Abstract available


  202. HARROLD LR, Bingham CO, Pope JE, O'Brien J, et al
    Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.
    Clin Rheumatol. 2024 Dec 20. doi: 10.1007/s10067-024-07245.
    PubMed     Abstract available


  203. ZHAN W, Li R, Xu X
    The relationship between low-carbohydrate diet score, dietary macronutrient intake, and rheumatoid arthritis: results from NHANES 2011-2016.
    Clin Rheumatol. 2024 Dec 16. doi: 10.1007/s10067-024-07269.
    PubMed     Abstract available


  204. GUAJARDO-JAUREGUI N, Cardenas-de la Garza JA, Galarza-Delgado DA, Azpiri-Lopez JR, et al
    Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican coh
    Clin Rheumatol. 2024 Dec 10. doi: 10.1007/s10067-024-07249.
    PubMed     Abstract available


  205. YANG L, Wang X, Gu B, Su D, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
    Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
    PubMed     Abstract available


  206. FENG R, Xiao X, Wang Y, Huang B, et al
    Metabolic impact of low dose IL-2 therapy for primary Sjogren's Syndrome in a double-blind, randomized clinical trial.
    Clin Rheumatol. 2024;43:3789-3798.
    PubMed     Abstract available


  207. SHUAI XU, Dandan F, Liang XU
    Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
    Clin Rheumatol. 2024;43:3993-3998.
    PubMed     Abstract available


  208. TEIXEIRA RL, da Silva Vieira R, Saavedra MJ, Polido-Pereira J, et al
    Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study.
    Clin Rheumatol. 2024;43:3941-3950.
    PubMed     Abstract available


  209. WANG X, Wu H, Zhong B, Zhang L, et al
    Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:3781-3787.
    PubMed     Abstract available


  210. PENG LQ, Chen XH, Yang WJ, Huang WK, et al
    Can unstimulated whole salivary flow objectively classify salivary gland secretory function in Sjogren's syndrome?
    Clin Rheumatol. 2024;43:3771-3780.
    PubMed     Abstract available


    November 2024
  211. PANG X, Xu F, Fan C, Jiang H, et al
    Global research trends of MicroRNAs in rheumatoid arthritis: bibliometrics and visualization analysis.
    Clin Rheumatol. 2024 Nov 28. doi: 10.1007/s10067-024-07250.
    PubMed     Abstract available


  212. JIANG P, Shen Y, Chang C, Shi Y, et al
    HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 27. doi: 10.1007/s10067-024-07158.
    PubMed     Abstract available


  213. YAN L, Lin M, Ye X, Li W, et al
    Prediction model for bone erosion in rheumatoid arthritis based on musculoskeletal ultrasound and clinical risk factors.
    Clin Rheumatol. 2024 Nov 9. doi: 10.1007/s10067-024-07219.
    PubMed     Abstract available


  214. LYU Q, Ma L, Liu H, Shao H, et al
    Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study.
    Clin Rheumatol. 2024 Nov 5. doi: 10.1007/s10067-024-07179.
    PubMed     Abstract available


  215. DAGHOR-ABBACI K, Laraba N, Dahou-Makhloufi C, Mechid F, et al
    Disease activity score for still's disease.
    Clin Rheumatol. 2024;43:3273-3283.
    PubMed     Abstract available


  216. CAI X, Jin J, Ye H, Xiang X, et al
    Altered serum metabolome is associated with disease activity and immune responses in rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 1. doi: 10.1007/s10067-024-07201.
    PubMed     Abstract available


    October 2024
  217. MAHMOUD EM, Radwan A, Elsayed SA
    A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-alpha inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Oct 31. doi: 10.1007/s10067-024-07194.
    PubMed     Abstract available


  218. ROJAS-GUALDRON DF, Franco-Salazar C, Gomez-Henck CA, Manrique-Castrillon MC, et al
    Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 30. doi: 10.1007/s10067-024-07186.
    PubMed     Abstract available


  219. D'ONOFRIO B, Selmi C, Gremese E
    Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?
    Clin Rheumatol. 2024 Oct 26. doi: 10.1007/s10067-024-07187.
    PubMed     Abstract available


  220. LI S, Chen Z, Yu H, Chang W, et al
    Association of magnesium deficiency scores with risk of rheumatoid arthritis and osteoarthritis in adults: a cross-sectional population-based study.
    Clin Rheumatol. 2024 Oct 25. doi: 10.1007/s10067-024-07203.
    PubMed     Abstract available


  221. TAHIR MW, Rosli Y, Leung C, Wysham KD, et al
    Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study.
    Clin Rheumatol. 2024 Oct 19. doi: 10.1007/s10067-024-07200.
    PubMed     Abstract available


  222. SHIH PC, Hung PC, Leong PY, Hsu JN, et al
    Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.
    Clin Rheumatol. 2024 Oct 11. doi: 10.1007/s10067-024-07161.
    PubMed     Abstract available


  223. ZHAO CN, Jiang LQ, Musonye HA, Meng SY, et al
    Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2024 Oct 5. doi: 10.1007/s10067-024-07167.
    PubMed     Abstract available


  224. MOVAHEDI M, Cui K, Tomlinson G, Cesta A, et al
    Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 4. doi: 10.1007/s10067-024-07148.
    PubMed     Abstract available


  225. LIN Q, Zhang C, Huang H, Bai Z, et al
    TLR2 reprograms glucose metabolism in CD4(+) T cells of rheumatoid arthritis patients to mediate cell hyperactivation and TNF-alpha secretion.
    Clin Rheumatol. 2024 Oct 2. doi: 10.1007/s10067-024-07125.
    PubMed     Abstract available


  226. XIA Z, Zong S, Zhou S, Rao Y, et al
    Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation.
    Clin Rheumatol. 2024 Oct 1. doi: 10.1007/s10067-024-07164.
    PubMed     Abstract available


  227. PHAN K, Chou S, Lee AYS
    Isolated cutaneous panniculitis in Sjogren's disease exacerbated by COVID-19 illness.
    Clin Rheumatol. 2024;43:3257-3258.
    PubMed    


    September 2024
  228. SHI X
    Letter to the editor: "Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study".
    Clin Rheumatol. 2024 Sep 30. doi: 10.1007/s10067-024-07150.
    PubMed    


  229. ANJIKI K, Hayashi S, Ikuta K, Suda Y, et al
    JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.
    Clin Rheumatol. 2024 Sep 20. doi: 10.1007/s10067-024-07142.
    PubMed     Abstract available


  230. ZHANG L, Shen Y
    Letter to the editor to "Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study".
    Clin Rheumatol. 2024 Sep 19. doi: 10.1007/s10067-024-07112.
    PubMed    


  231. OU Y, Wu J, Zhu Y, Qi X, et al
    Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 12. doi: 10.1007/s10067-024-07119.
    PubMed     Abstract available


  232. HAYASHI S, Nakano N, Tsubosaka M, Kamenaga T, et al
    Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 7. doi: 10.1007/s10067-024-07117.
    PubMed     Abstract available


  233. SUAREZ-ALMAZOR ME, Ruiz JI, Lei X, Wu CF, et al
    Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer.
    Clin Rheumatol. 2024 Sep 4. doi: 10.1007/s10067-024-07135.
    PubMed     Abstract available


  234. ZAYENI H, Sojoudi S, Ghanbari AM, Masooleh IS, et al
    The effect of radiation synovectomy with phosphorus-32 on the pain and swelling in 31 RA patients with resistant monoarthritis of the knee.
    Clin Rheumatol. 2024;43:2791-2798.
    PubMed     Abstract available


    August 2024
  235. WANG X, Bai Y, Zou X, He X, et al
    Exploring the role of Life Essential 8 in patients diagnosed with systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 21. doi: 10.1007/s10067-024-07114.
    PubMed     Abstract available


  236. MALANI K, Pradhan S, Roberts M, Saquib N, et al
    Joint effect of rheumatoid arthritis and diet quality on cardiovascular and mortality outcomes: insights from the Women's Health Initiative.
    Clin Rheumatol. 2024 Aug 4. doi: 10.1007/s10067-024-07092.
    PubMed     Abstract available


  237. WANG X, Yang J, Yu LY, Zhang J, et al
    Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07084.
    PubMed     Abstract available


  238. CHEN DY
    Reply to "Letter to the Editor": Exploring Multidimensional Factors of Herpes Zoster Risk in Rheumatoid Arthritis Patients Undergoing JAK Inhibitor Treatment.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07087.
    PubMed    


  239. JERIES H, Daood R, Naffaa ME
    Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?
    Clin Rheumatol. 2024;43:2715-2717.
    PubMed    


  240. ZHU H, Wang Y, Wang G, Ling Y, et al
    The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjogren's syndrome.
    Clin Rheumatol. 2024;43:2585-2594.
    PubMed     Abstract available


    July 2024
  241. PARK E, Iqbal R, Giles JT, Bernstein EJ, et al
    Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis-associated interstitial lung disease: a survey of rheumatologists.
    Clin Rheumatol. 2024 Jul 31. doi: 10.1007/s10067-024-07068.
    PubMed    


  242. GU H, Yan D, Li J, Long X, et al
    Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.
    Clin Rheumatol. 2024 Jul 29. doi: 10.1007/s10067-024-07083.
    PubMed     Abstract available


  243. TONG B, Cheng W
    Letter to editor 'Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease'.
    Clin Rheumatol. 2024 Jul 22. doi: 10.1007/s10067-024-07075.
    PubMed    


  244. ZHOU L, Xing Y, Li W
    Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment.
    Clin Rheumatol. 2024 Jul 20. doi: 10.1007/s10067-024-07076.
    PubMed    


  245. NOVELLA-NAVARRO M, Ruiz-Esquide V, Lopez-Juanes N, Chacur CA, et al
    Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
    Clin Rheumatol. 2024 Jul 16. doi: 10.1007/s10067-024-07070.
    PubMed     Abstract available


  246. CHEN PK, Chang SH, Chen YM, Chen HH, et al
    Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
    Clin Rheumatol. 2024 Jul 2. doi: 10.1007/s10067-024-07041.
    PubMed     Abstract available


  247. FAYET F, Darmant N, Lambert C, Pereira B, et al
    Effect of Argentine tango sessions on total physical activity time in patients with chronic inflammatory rheumatism: randomized, controlled, pilot study.
    Clin Rheumatol. 2024;43:2215-2221.
    PubMed     Abstract available


  248. SOLTANI F, Khalaji A, Farzaneh R, Malek Mahdavi A, et al
    Performance of existing diagnostic criteria for palindromic rheumatism.
    Clin Rheumatol. 2024;43:2337-2342.
    PubMed     Abstract available


  249. ANSARI N, Salesi M
    The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.
    Clin Rheumatol. 2024;43:2177-2186.
    PubMed     Abstract available


    June 2024
  250. WANG W, Xu Y, Zhou J, Zang Y, et al
    Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07040.
    PubMed     Abstract available


  251. JANAHIRAMAN S, Shahril NS, Jayaraj VJ, Ch'ng S, et al
    A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07035.
    PubMed     Abstract available


  252. LIU F, Liu F, Wang H
    Association between Life's Essential 8 and rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 24. doi: 10.1007/s10067-024-07036.
    PubMed     Abstract available


  253. VENKAT RK, Hayashi K, Juge PA, McDermott G, et al
    Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 Jun 19. doi: 10.1007/s10067-024-07028.
    PubMed     Abstract available


  254. GADEHOLT O, Arnold E, Gorman C, Mueller T, et al
    Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 14. doi: 10.1007/s10067-024-07032.
    PubMed     Abstract available


  255. HARRIS JT, Yang Y, Bentley JP, Chen Y, et al
    Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 10. doi: 10.1007/s10067-024-06971.
    PubMed     Abstract available


  256. OPDAM MAA, Broeder ND, van den Bemt BJF, Mulder K, et al
    Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
    Clin Rheumatol. 2024;43:2133-2138.
    PubMed     Abstract available


  257. SARIYILDIZ A, Coskun Benlidayi I, Yetisir A, Turk I, et al
    Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1949-1958.
    PubMed     Abstract available


  258. GOLOVINA OA, Torgashina AV, Gorodetskiy VR, Sockol EV, et al
    Combination of Sjogren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.
    Clin Rheumatol. 2024;43:2145-2152.
    PubMed     Abstract available


  259. LIU H, Yuan J, Tan X, Song W, et al
    Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
    Clin Rheumatol. 2024;43:1927-1937.
    PubMed     Abstract available


  260. XIE Y, Fan Y, Su M, Wang Y, et al
    Characteristics of the oral microbiota in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1939-1947.
    PubMed     Abstract available


  261. EL MIEDANY Y, El Gaafary M, Youssef S, El Aroussy N, et al
    Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
    Clin Rheumatol. 2024;43:1793-1801.
    PubMed     Abstract available


    May 2024
  262. CHEN G, Chen H, Wang Z, Cai H, et al
    Letter to the editor: "Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis".
    Clin Rheumatol. 2024 May 18. doi: 10.1007/s10067-024-07006.
    PubMed    


  263. ABDULSALAM AJ, Analay P, Kara M
    Sarcopenia in rheumatoid arthritis: choose your weapons wisely.
    Clin Rheumatol. 2024 May 13. doi: 10.1007/s10067-024-07002.
    PubMed    


  264. MURPHY L, Saab MM, Cornally N, McHugh S, et al
    Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review.
    Clin Rheumatol. 2024 May 11. doi: 10.1007/s10067-024-06996.
    PubMed     Abstract available


  265. WAN J, Yu Z, Cao X, Zhao X, et al
    Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 May 5. doi: 10.1007/s10067-024-06984.
    PubMed     Abstract available


  266. HU W, Ding Y, Guan K, Zhang P, et al
    Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy.
    Clin Rheumatol. 2024 May 2. doi: 10.1007/s10067-024-06982.
    PubMed     Abstract available


  267. XU N, Wang X, Dai T, Liu N, et al
    Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
    Clin Rheumatol. 2024;43:1683-1692.
    PubMed     Abstract available


  268. LU L, Dai T, Zhao Y, Qu H, et al
    The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1675-1682.
    PubMed     Abstract available


  269. CAI B, Guo Z, Yan Q, Li H, et al
    Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
    Clin Rheumatol. 2024;43:1665-1674.
    PubMed     Abstract available


  270. AN Q, Ma R, Yuan D, Huang J, et al
    Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
    Clin Rheumatol. 2024;43:1491-1501.
    PubMed     Abstract available


  271. LI H, Jin Y, He J
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:1777.
    PubMed    


    April 2024
  272. SEPRIANO A, Ramiro S, Landewe R, van der Heijde D, et al
    Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
    Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06978.
    PubMed     Abstract available


  273. LOZADA-MELLADO M, Llorente L, Hinojosa-Azaola A, Ogata-Medel M, et al
    Inflammatory profile in patients with rheumatoid arthritis and sarcopenia.
    Clin Rheumatol. 2024 Apr 26. doi: 10.1007/s10067-024-06974.
    PubMed     Abstract available


  274. SHEAHAN A, Anjohrin S, Suruki R, Stark JL, et al
    Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
    Clin Rheumatol. 2024 Apr 25. doi: 10.1007/s10067-024-06945.
    PubMed     Abstract available


  275. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
    Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
    Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
    PubMed     Abstract available


  276. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
    Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
    Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
    PubMed     Abstract available


  277. ZHOU J, Gan Y, Fan X, Qi H, et al
    Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey.
    Clin Rheumatol. 2024 Apr 10. doi: 10.1007/s10067-024-06959.
    PubMed     Abstract available


  278. YU T, Qian S, Li M
    Letter to the Editor: "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis".
    Clin Rheumatol. 2024 Apr 6. doi: 10.1007/s10067-024-06924.
    PubMed    


  279. OLIVEIRA D, Ferreira RM, Gomes CM, Vaz C, et al
    Geiser Sign in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2024 Apr 4. doi: 10.1007/s10067-024-06952.
    PubMed    


  280. XIE Y, Zhao H
    Real respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1353.
    PubMed    


  281. DAI W, He H
    Commentary on the respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1419-1420.
    PubMed    


  282. LIU X, Wang H, Wang X, Jiang X, et al
    Identification and verification of inflammatory biomarkers for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1335-1352.
    PubMed     Abstract available


    March 2024
  283. BIRD A, Oakden-Rayner L, Smith LA, Zeng M, et al
    Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
    Clin Rheumatol. 2024 Mar 27. doi: 10.1007/s10067-024-06946.
    PubMed     Abstract available


  284. GUPTA N, Kanwar N, Arora A, Khatri K, et al
    The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
    Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
    PubMed     Abstract available


  285. LU F, Chen Q, Qi X, Cong M, et al
    Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters.
    Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
    PubMed     Abstract available


  286. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
    PubMed    


  287. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
    Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
    Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
    PubMed     Abstract available


  288. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
    Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
    PubMed     Abstract available


  289. PAN J, Wu T, Ma JD, Jia PW, et al
    Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Mar 4. doi: 10.1007/s10067-024-06918.
    PubMed     Abstract available


  290. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    PubMed     Abstract available


  291. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    PubMed     Abstract available


  292. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    PubMed     Abstract available


  293. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    PubMed     Abstract available


  294. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    PubMed    


    February 2024
  295. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    PubMed    


  296. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    PubMed     Abstract available


  297. FERNANDEZ-AVILA DG, Patino-Hernandez D, Moreno-Luna S, Brance L, et al
    Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 14. doi: 10.1007/s10067-024-06868.
    PubMed     Abstract available


  298. LICHTIGER A, Fadaei G, Tagoe CE
    Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
    Clin Rheumatol. 2024 Feb 10. doi: 10.1007/s10067-024-06888.
    PubMed     Abstract available


  299. NOMAIR AM, Abdelati A, Dwedar FI, Elnemr R, et al
    The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Feb 5. doi: 10.1007/s10067-024-06892.
    PubMed     Abstract available


  300. ZHANG L, Tan M, Mao J, Zhang J, et al
    Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
    PubMed     Abstract available


  301. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
    Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
    Clin Rheumatol. 2024;43:733-741.
    PubMed     Abstract available


  302. ZHAO R, Dong C, Gu Z, Ding X, et al
    Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:717-724.
    PubMed     Abstract available


  303. ZHOU X, Li H, Wang N, Jin Y, et al
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:707-715.
    PubMed     Abstract available


  304. SHEN Y, Yu X, Wang Q, Yao X, et al
    Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
    Clin Rheumatol. 2024;43:603-619.
    PubMed     Abstract available


    January 2024
  305. O'BRIEN J, Park SH, Blachley T, Marchese M, et al
    Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
    Clin Rheumatol. 2024 Jan 25. doi: 10.1007/s10067-024-06869.
    PubMed     Abstract available


  306. QIAO L, Lv S, Meng K, Yang J, et al
    Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Clin Rheumatol. 2024 Jan 10. doi: 10.1007/s10067-023-06837.
    PubMed     Abstract available


  307. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Jan 6. doi: 10.1007/s10067-023-06862.
    PubMed     Abstract available


  308. SHIZUKU T, Hagino N
    Hypoglossal nerve palsy due to basilar impression in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jan 3. doi: 10.1007/s10067-023-06863.
    PubMed    


  309. YIN S, Luo F, Xie J, Zeng Y, et al
    Identification of discriminatory factors and construction of nomograms for differentiating AOSD and sepsis.
    Clin Rheumatol. 2024;43:569-578.
    PubMed     Abstract available


  310. RUAN Y, Bi H, Luo X, Pang A, et al
    Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjogren syndrome with thrombocytopenia.
    Clin Rheumatol. 2024;43:307-314.
    PubMed     Abstract available


  311. SAMI F, Sami SA, Manadan AM, Arora S, et al
    Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
    Clin Rheumatol. 2024;43:59-65.
    PubMed     Abstract available


  312. FARES J, Summer R, Loizidis G
    Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
    Clin Rheumatol. 2024;43:325-338.
    PubMed     Abstract available


  313. CHEN L, Chi H, Teng J, Meng J, et al
    Neutralizing anti-IFN-gamma IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
    Clin Rheumatol. 2024;43:189-198.
    PubMed     Abstract available


  314. ZHAO P, Peng C, Chang X, Cheng W, et al
    Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:297-306.
    PubMed     Abstract available


  315. KIADALIRI A, Dell'Isola A, Englund M
    Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Clin Rheumatol. 2024;43:81-85.
    PubMed     Abstract available


  316. CAI D, Zheng Z, Hu J, Fu Y, et al
    Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
    Clin Rheumatol. 2024;43:533-541.
    PubMed     Abstract available


    December 2023
  317. SLOUMA M, Lahmar W, Mohamed G, Dhrif O, et al
    Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2023 Dec 30. doi: 10.1007/s10067-023-06847.
    PubMed     Abstract available


  318. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
    Clin Rheumatol. 2023 Dec 28. doi: 10.1007/s10067-023-06850.
    PubMed     Abstract available


  319. OZUDOGRU CELIK T
    Letter to the Editor on "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06823.
    PubMed    


  320. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    Rebuttal Letter to "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06856.
    PubMed    


  321. D'ALESSANDRO F, Cazzato M, Laurino E, Morganti R, et al
    ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study
    Clin Rheumatol. 2023 Dec 23. doi: 10.1007/s10067-023-06836.
    PubMed     Abstract available


  322. LIU H, Zhang Y, Cao J, Li J, et al
    Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.
    Clin Rheumatol. 2023 Dec 14. doi: 10.1007/s10067-023-06840.
    PubMed     Abstract available


  323. MO H, Su ZH, Zheng ZY, Gao L, et al
    Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection.
    Clin Rheumatol. 2023 Dec 5. doi: 10.1007/s10067-023-06830.
    PubMed     Abstract available


  324. KARAMALI N, Mahmoudi Z, Roghani SA, Assar S, et al
    Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
    Clin Rheumatol. 2023 Dec 4. doi: 10.1007/s10067-023-06808.
    PubMed     Abstract available


  325. HE J, Xu C, Zhu Y, Xu M, et al
    Clinical significance of the expression levels of serum transforming growth factor-beta and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
    Clin Rheumatol. 2023;42:3283-3288.
    PubMed     Abstract available


  326. SCHMIDT NS, Fana V, Danielsen MA, Lindegaard HM, et al
    The impact of an ultrasound atlas for scoring salivary glands in primary Sjogren's syndrome: a pilot study.
    Clin Rheumatol. 2023;42:3275-3281.
    PubMed     Abstract available


  327. YIN H, Yang S, Lu L
    Adie's tonic pupil in primary Sjogren syndrome.
    Clin Rheumatol. 2023;42:3419-3420.
    PubMed    


    November 2023
  328. SHAMSI A, Roghani SA, Soufivand P, Pournazari M, et al
    CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 25. doi: 10.1007/s10067-023-06826.
    PubMed     Abstract available


  329. PALMOWSKI A, Strehl C, Pfeiffenberger M, Haupl T, et al
    Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 17. doi: 10.1007/s10067-023-06814.
    PubMed     Abstract available


  330. RONG JC, Chen XD, Jin NK, Hong J, et al
    Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
    Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06804.
    PubMed     Abstract available


  331. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
    Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
    Clin Rheumatol. 2023;42:3033-3041.
    PubMed     Abstract available


  332. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
    Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
    Clin Rheumatol. 2023;42:3143-3152.
    PubMed     Abstract available


  333. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
    Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
    Clin Rheumatol. 2023;42:3021-3031.
    PubMed     Abstract available


  334. WISE L, Zell M
    Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
    Clin Rheumatol. 2023;42:3159-3166.
    PubMed     Abstract available


    October 2023
  335. ADELOWO O, Omokhowa A, Ochiagha O, Uhunmwangho CU, et al
    Comorbidities in Nigerian patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 23. doi: 10.1007/s10067-023-06797.
    PubMed     Abstract available


  336. VALLEZ-VALERO L, Gaso-Gago I, Marcos-Fendian A, Garrido-Alejos G, et al
    Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06787.
    PubMed     Abstract available


  337. LI WJ, Wang XL, Chu YR, Wang JX, et al
    Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06784.
    PubMed     Abstract available


  338. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients.
    Clin Rheumatol. 2023 Oct 9. doi: 10.1007/s10067-023-06780.
    PubMed     Abstract available


  339. PAN S, Xiao X, Li T, Wu S, et al
    Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 4. doi: 10.1007/s10067-023-06772.
    PubMed     Abstract available


  340. TESCH F, Ehm F, Vivirito A, Wende D, et al
    Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
    Clin Rheumatol. 2023;42:2905-2914.
    PubMed     Abstract available


  341. ZIMBA O, Gasparyan AY
    Cardiovascular issues in rheumatic diseases.
    Clin Rheumatol. 2023;42:2535-2539.
    PubMed     Abstract available


  342. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Clin Rheumatol. 2023;42:2677-2690.
    PubMed     Abstract available


    September 2023
  343. WEINSTEIN CLJ, Meehan AG, Lin J, Briscoe SD, et al
    Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Clin Rheumatol. 2023 Sep 26. doi: 10.1007/s10067-023-06760.
    PubMed     Abstract available


  344. LIU H, Li Q, Long K, Xia O, et al
    Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
    Clin Rheumatol. 2023 Sep 23. doi: 10.1007/s10067-023-06773.
    PubMed     Abstract available


  345. NAKAYAMA M, Furuya T, Inoue E, Tanaka E, et al
    Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
    Clin Rheumatol. 2023 Sep 21. doi: 10.1007/s10067-023-06779.
    PubMed     Abstract available


  346. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
    Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 14. doi: 10.1007/s10067-023-06768.
    PubMed    


  347. CHEN YW, Chen HH, Huang WN, Chen JP, et al
    Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 2. doi: 10.1007/s10067-023-06735.
    PubMed     Abstract available


    November 2022
  348. CANSU DU, Korkmaz C
    Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum